Found: 31
Select item for more details and to access through your institution.
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1483, doi. 10.1007/s10637-020-00908-3
- By:
- Publication type:
- Article
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 271, doi. 10.1007/s10637-018-0627-4
- By:
- Publication type:
- Article
Regional activation of chromosomal arm 7q with and without gene amplification in taxane‐selected human ovarian cancer cell lines.
- Published in:
- Genes, Chromosomes & Cancer, 2006, v. 45, n. 4, p. 365, doi. 10.1002/gcc.20300
- By:
- Publication type:
- Article
Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221119370
- By:
- Publication type:
- Article
Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 3, p. 649, doi. 10.1007/s10549-019-05206-y
- By:
- Publication type:
- Article
A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 605, doi. 10.1007/s10549-018-05079-7
- By:
- Publication type:
- Article
Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.
- Published in:
- NPJ Precision Oncology, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41698-019-0090-5
- By:
- Publication type:
- Article
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Single-cell barcode analysis provides a rapid readout of cellular signaling pathways in clinical specimens.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07002-6
- By:
- Publication type:
- Article
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01132-z
- By:
- Publication type:
- Article
Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 9, p. 1413, doi. 10.2967/jnumed.115.169417
- By:
- Publication type:
- Article
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1094, doi. 10.1093/oncolo/oyad280
- By:
- Publication type:
- Article
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 358, doi. 10.1093/oncolo/oyac281
- By:
- Publication type:
- Article
Cell Atlas of The Human Fovea and Peripheral Retina.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66092-9
- By:
- Publication type:
- Article
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25859-y
- By:
- Publication type:
- Article
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-20139-7
- By:
- Publication type:
- Article
Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.
- Published in:
- Nature, 2015, v. 518, n. 7538, p. 240, doi. 10.1038/nature13948
- By:
- Publication type:
- Article
Cancer Cell Profiling by Barcoding Allows Multiplexed Protein Analysis in Fine-Needle Aspirates.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 219, p. 1, doi. 10.1126/scitranslmed.3007361
- By:
- Publication type:
- Article
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 196, p. 1, doi. 10.1126/scitranslmed.3005747
- By:
- Publication type:
- Article
First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.6776
- By:
- Publication type:
- Article
Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 3, p. 543, doi. 10.1111/bcp.12378
- By:
- Publication type:
- Article
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer.
- Published in:
- Science Signaling, 2014, v. 7, n. 318, p. 1, doi. 10.1126/scisignal.2005125
- By:
- Publication type:
- Article
Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.786120
- By:
- Publication type:
- Article
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00613-x
- By:
- Publication type:
- Article
Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00528-z
- By:
- Publication type:
- Article
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00490-2
- By:
- Publication type:
- Article
Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00311-y
- By:
- Publication type:
- Article
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01773-1
- By:
- Publication type:
- Article
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article